Markets

Analyst Bets on Extraordinary Science and Clinical Data: Greg Wade

Analyst Bets on Extraordinary Science and Clinical Data: Greg Wade

Source: George S. Mack of The Life Sciences Report (8/30/12)

http://www.thelifesciencesreport.com/pub/na/14232

Managing Director Greg Wade of Wedbush Securities doesn't use a cookie-cutter approach to picking biotechnology stocks. He directs investors to companies with strong science, well-executed clinical studies and data that points toward future success. In this exclusive interview with The Life Sciences Report , Wade shares his favorite names and the compelling stories behind each company.

Read More on International Business Times

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Commodities